People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Micron Biomedical, Inc. | — | Biotechnology | Series A | $32.0M | $63.5M | 2022 |
Bas Van Buijtenen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bas Van Buijtenen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Goldman | 1 | 5 |
| Mark Prausnitz | 1 | 2 |
| Brian Bernick | 1 | 2 |
| Idean Marvasty | 1 | 2 |
| Steven Damon | 1 | 2 |
| Henry Sebastien | 1 | 1 |
| Steve Damon | 1 | 1 |
| Labeeb Abboud | 1 | 1 |
| Devin McAllister | 1 | 1 |
| Sebastien Henry | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.